Extracellular matrix glycosaminoglycans can predict severity and outcome in COPD
E. Papakonstantinou (Basel, Switzerland), I. Bonovolias (Thessaloniki, Greece), G. Karakiulakis (Thessaloniki, Greece), M. Tamm (Basel, Switzerland), R. Louis (Liege, Belgium), B. Milenkovic (Belgrade, Republic of Serbia), W. Boersma (Alkmaar, Netherlands), K. Kostikas (Larissa, Greece), F. Blassi (Milan, Italy), J. Aerts (Breda, Netherlands), G. Rohde (Maastrict, Netherlands), A. Lacoma (Badalona, Spain), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), D. Stolz (Basel, Switzerland)
Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Disease area: Airway diseases
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Related content which might interest you: